On the 25th day of February 2015 the Ukrainian Pharmaceutical Quality Institute will arrange the conference on “Peculiarities of import of medicinal products and medical devices to Ukraine”.
Legal Alliance invites to visit the event all managers of incorporated businesses performing import of medicinal products and medical devices; managers and specialists of financial and legal services, directors on international economic activity of pharmaceutical manufacturers, and other specialists involved in these processes.
As speakers there have been invited representatives of MH of Ukraine, State service of Ukraine for medicinal products, State customs service of Ukraine etc.
The conference will include consideration of questions concerning import of non-registered medicinal products and medical devices, including for the purposes of ATO; practical aspects of importation of medicinal products and medical devices, application of customs law by their importation; specific features of customs registration of substances and products in bulk; Ukrainian law concerning customs registration of medicinal products and medical devices; some peculiarities of price determination for medicinal products and medical devices, procedure of its approval.
Agenda and details are availiable on Russuan by link: http://uphiq.org/html/seminars/custom/custom.html
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
